– The grant will enable the first clinical trials to study the potential of brain-computer interfaces (BCI) and artificial intelligence technologies to restore thought-controlled movements after a stroke.
– The funding will also support the technological development of the ARC-BCI system and the ARC-IM® probe.
– Every year, around 15 million people around the world suffer a stroke.
EINDHOVEN, Netherlands, November 19, 2024 – ONWARD Medical NV (Euronext: ONWD), a medical technology company behind innovative therapies* to restore movement, function and independence in people with spinal injuries. Spinal Cord (SCI), announces the receipt of a grant from the European Innovation Council (EIC) to study the use of its investigational therapy ARC-BCI to restore upper limb movement after stroke subcortical.
“While our primary focus remains helping people with spinal cord injuries, this grant highlights the potential of our innovative therapies for people with other motor disabilities, such as stroke,” said Dave Marver, CEO of ONWARD Medical.
Find the full press release below:
Health
Related News :